Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 2/20 | 0.50 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.50 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.50 |
| ▸ | ACP3 | P15309 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.46 |
| ▸ | SCN4A | P35499 | 2/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 2/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8067078 | 1.00 | ANPEP (0.50) | ANPEPERAP1ERAP2ACP3KCNH2 | |
| SCHEMBL5924988 | 1.00 | ANPEP (0.50) | ANPEPERAP1ERAP2ACP3KCNH2 | |
| Hydrochloric Acid SCHEMBL9635016 | 0.98 | ANPEP (0.48) | ANPEPERAP1ERAP2ACP3KCNH2 | |
| SCHEMBL6432692 | 0.95 | ANPEP (0.50) | ANPEPERAP1ERAP2ACP3KCNH2 | |
| SCHEMBL20725551 | 0.90 | ANPEP (0.46) | ANPEPERAP1ERAP2ACP3KCNH2 | |
| SCHEMBL8631288 | 0.87 | KCNH2 (0.50) | KCNH2HTR2A | |
| SCHEMBL28015148 | 0.86 | ANPEP (0.40) | ANPEPERAP1ERAP2ACP3KCNH2 | |
| SCHEMBL27549431 | 0.86 | ADRA1A (0.51) | ANPEPERAP1ERAP2KCNH2HTR2A | |
| SCHEMBL10345872 | 0.85 | MAOA (0.52) | KCNH2HTR2A | |
| SCHEMBL7022054 | 0.85 | MAOA (0.52) | KCNH2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 874 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4660194-A1 | SALT AND CRYSTAL FORM OF CYCLOALKENE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CN) | 2025-12-10 | — | — | EP | claimed |
| CN-119486735-A | For the treatment of glomerular diseases | 载度思生命科学有限公司 | 2025-02-18 | — | — | CN | claimed |
| WO-2024160271-A1 | SALT AND CRYSTAL FORM OF CYCLOALKENE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 江苏豪森药业集团有限公司 | 2024-08-08 | — | — | WO | claimed |
| US-20230404958-A1 | AGENT FOR INHIBITING RENAL DAMAGE INDUCED BY RHABDOMYOLYSIS | DENKA COMPANY LIMITED (JP) | 2023-12-21 | — | — | US | claimed |
| US-20230390229-A1 | PREVENTION OF KIDNEY INJURY INDUCED BY HEMOLYTIC REACTION | DENKA COMPANY LIMITED (JP) | 2023-12-07 | — | — | US | claimed |
| CN-113164368-B | High-content and sustained-release retinoid capsule and wrinkle-improving composition containing same | 株式会社LG生活健康 | 2023-06-13 | — | — | CN | claimed |
| CN-107466322-B | Mutant transaminases and methods and uses related thereto | 豪夫迈·罗氏有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-107474208-B | A kind of multi-functional benzoxazine composite material and preparation method | 四川天策聚材科技有限公司 | 2019-10-22 | — | — | CN | claimed |
| CN-110156982-A | A kind of liquid liquid homogeneous method using continuous flow micro passage reaction synthesis polyarylether | 常州中英新材料有限公司 | 2019-08-23 | — | — | CN | claimed |
| CN-110156983-A | Liquid-liquid heterogeneous method for synthesizing polyarylether by using continuous flow microchannel reactor | 常州中英新材料有限公司 | 2019-08-23 | — | — | CN | claimed |
| WO-2009056993-A2 | A PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2009-05-07 | — | — | WO | claimed |
| CN-101405279-A | Process for preparing substituted aryl cycloalkanol derivatives | WYETH CORP (US) | 2009-04-08 | — | — | CN | claimed |
| CN-1901902-A | Thiophene and benzothiophene hydroxamic acid derivatives | ATON PHARMA INC (US) | 2007-01-24 | — | — | CN | claimed |
| WO-2001005401-A1 | MELANOCORTIN RECEPTOR-3 LIGANDS TO TREAT SEXUAL DYSFUNCTION | TREGA BIOSCIENCES, INC. (US) | 2001-01-25 | — | — | WO | claimed |
| US-6060617-A | REACTING AN ALKALI METAL HYDRIDE AND ALKALI METAL AMIDES WITH A SUBSTITUTED AMINE IN AN ETHER SOLVENT IN ABSENCE OF AN ELECTRON CARRIER TO PRODUCE AN ALKALI METAL AMIDE FREE OF ORGANIC CONTAMINANTS | FMC CORPORATION (US) | 2000-05-09 | — | — | US | claimed |
| EP-0843682-A1 | HIGH PURITY FORMULATIONS OF HIGHLY SUBSTITUTED LITHIUM AMIDE BASES | FMC CORPORATION (US) | 1998-05-27 | — | — | EP | claimed |
| US-5726308-A | High purity formulations of highly substituted lithium amide bases | FMC CORPORATION (US) | 1998-03-10 | — | — | US | claimed |
| WO-1997006173-A1 | HIGH PURITY FORMULATIONS OF HIGHLY SUBSTITUTED LITHIUM AMIDE BASES | FMC CORPORATION (US) | 1997-02-20 | — | — | WO | claimed |
| US-4902707-A | Bicyclic pyrazolidinones, compositions and use | ELI LILLY AND COMPANY (US) | 1990-02-20 | — | — | US | claimed |
| EP-0142463-A2 | Method of producing prepregs and composite materials reinforced therewith | CIBA-GEIGY AG (CH) | 1985-05-22 | — | — | EP | claimed |